Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Agency Summary Page
Agency Name: Justice Department Civil Division
Penalty Total since 2000: $78,256,072,620
Number of Records: 1,221
Note: The parent penalty totals are adjusted to account for the fact that the list of individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent Companies | Total Penalty $ | Number of Records |
Purdue Pharma | $8,344,000,000 | 1 |
Deutsche Bank | $7,200,000,000 | 1 |
UBS | $6,715,000,000 | 2 |
Wells Fargo | $6,290,000,000 | 3 |
NatWest Group PLC | $4,900,000,000 | 1 |
Tenet Healthcare | $1,663,454,065 | 14 |
Merck | $1,522,000,000 | 4 |
General Electric | $1,520,780,000 | 4 |
HCA Healthcare | $1,512,375,097 | 6 |
UnitedHealth Group | $1,248,839,180 | 8 |
Individual Penalty Records:
Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Penalty Amount |
JPMorgan Chase | JPMorgan Chase | financial services | False Claims Act and related | 2014 | $614,000,000 |
Boeing Company | Boeing | aerospace and military contracting | False Claims Act and related | 2006 | $615,000,000 |
AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | False Claims Act and related | 2018 | $625,000,000 |
HCA Inc. | HCA Healthcare | healthcare services | False Claims Act and related | 2003 | $631,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | False Claims Act and related | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000 |
Merck & Company | Merck | pharmaceuticals | False Claims Act and related | 2008 | $650,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | $784,600,000 |
HCA-The Healthcare Company | HCA Healthcare | healthcare services | False Claims Act and related | 2000 | $840,000,000 |
Moody's Corporation | Moody's | information technology | toxic securities abuses | 2017 | $864,000,000 |
TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | $875,000,000 |
Tenet Healthcare Corporation | Tenet Healthcare | healthcare services | False Claims Act and related | 2006 | $900,000,000 |
Biogen Inc. | Biogen | pharmaceuticals | False Claims Act and related | 2022 | $900,000,000 |
Wells Fargo Bank, National Association | Wells Fargo | financial services | False Claims Act and related | 2016 | $1,200,000,000 |
UBS AG | UBS | financial services | toxic securities abuses | 2023 | $1,435,000,000 |
General Electric | General Electric | diversified | toxic securities abuses | 2019 | $1,500,000,000 |
Wells Fargo Bank, N.A. | Wells Fargo | financial services | toxic securities abuses | 2018 | $2,090,000,000 |
Wells Fargo & Company | Wells Fargo | financial services | fraud | 2020 | $3,000,000,000 |
Royal Bank of Scotland Group plc | NatWest Group PLC | financial services | toxic securities abuses | 2018 | $4,900,000,000 |
Credit Suisse | UBS | financial services | toxic securities abuses | 2017 | $5,280,000,000 |
Deutsche Bank | Deutsche Bank | financial services | toxic securities abuses | 2017 | $7,200,000,000 |
Purdue Pharma LP | Purdue Pharma | pharmaceuticals | fraud | 2020 | $8,344,000,000 |